Kleanthis G. Xanthopoulos, Ph. D.
President & Chief Executive Officer
"The Impact of microRNA Medicines"
Garry E. Menzel, Ph. D.
Chief Operating Officer & Executive Vice President of Finance
"Business Strategy and Focus"
Neil W. Gibson, Ph. D.
Chief Scientific Officer
"microRNAs as a New Class of Drug Targets"
Senior Vice President of Human Capital
"Culture and Core Values"